|
Neonatal Intensive Care Drug Manual
|
| bet | 650/654 | | Sana | 03.01.2022 | | Hajmi | 1,5 Mb. | | #14803 |
Zidovudine
Revision Date : 16-11-2020
|
Approved TC, KOH
|
Alert
|
No Australian registered intravenous products are available. Retrovir IV ampoules are only available via the Special Access Scheme (SAS) in Australia.
Also known as azidothymidine (AZT).
|
Indication
|
Monotherapy or part of a combination therapy for prevention of maternal-foetal HIV transmission.
|
Action
|
Nucleoside analogue that inhibits HIV replication by interfering with viral reverse transcriptase.
|
Drug type
|
Antiretroviral medication
|
Trade name
|
Retrovir
|
Presentation
|
Oral: syrup 10 mg/mL
IV: 10 mg/mL in a 20mL single-use vial (SAS)
Note: Retrovir is also available in oral capsules, however only the syrup is used in neonates.
|
|
|
| |
